Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm,multicentre, phase 2 trial |
| |
| Affiliation: | 1. Department of Radiation Oncology, University Hospital Basel, Basel, Switzerland;2. Department of Urology, University of Tuebingen, Tuebingen, Germany;3. Department of Radiation Oncology, University of Tuebingen, Tuebingen, Germany;4. Competence Center of SAKK—Swiss Group for Clinical Cancer Research, Bern, Switzerland;5. Medical Oncology, Kantonsspital Winterthur, Winterthur, Switzerland;6. Department of Hematology and Oncology, Red Cross Hospital Munich, Munich, Germany;7. Department of Urology, Pediatric Urology and Urologic Oncology, Kliniken Essen-Mitte, Essen, Germany;8. Department of Urology, University Hospital Duesseldorf, Duesseldorf, Germany;9. Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland;10. Department of Radiation Oncology, University Hospital of Bern, Bern, Switzerland;11. Department of Radiation Oncology, Kantonsspital St Gallen, St Gallen, Switzerland;12. Department of Medical Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;13. Department of Oncology, Kantonsspital Aarau, Aarau, Switzerland;14. Department of Urology, University Hospital of Ulm, Germany, Germany;15. Department of Internal Medicine, Hematology and Oncology, Vivantes Klinikum am Urban, Berlin, Germany;p. Istituto Oncologico della Svizzera Italiana, Ente Ospedaliero Cantonale Bellinzona, Switzerland;q. Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland;r. Division of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
